Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
16 07 2019
Historique:
entrez: 17 7 2019
pubmed: 17 7 2019
medline: 1 8 2019
Statut: ppublish

Résumé

Keeping a diary for patients while they are in the intensive care unit (ICU) might reduce their posttraumatic stress disorder (PTSD) symptoms. To assess the effect of an ICU diary on the psychological consequences of an ICU hospitalization. Assessor-blinded, multicenter, randomized clinical trial in 35 French ICUs from October 2015 to January 2017, with follow-up until July 2017. Among 2631 approached patients, 709 adult patients (with 1 family member each) who received mechanical ventilation within 48 hours after ICU admission for at least 2 days were eligible, 657 were randomized, and 339 were assessed 3 months after ICU discharge. Patients in the intervention group (n = 355) had an ICU diary filled in by clinicians and family members. Patients in the control group (n = 354) had usual ICU care without an ICU diary. The primary outcome was significant PTSD symptoms, defined as an Impact Event Scale-Revised (IES-R) score greater than 22 (range, 0-88; a higher score indicates more severe symptoms), measured in patients 3 months after ICU discharge. Secondary outcomes, also measured at 3 months and compared between groups, included significant PTSD symptoms in family members; significant anxiety and depression symptoms in patients and family members, based on a Hospital Anxiety and Depression Scale score greater than 8 for each subscale (range, 0-42; higher scores indicate more severe symptoms; minimal clinically important difference, 2.5); and patient memories of the ICU stay, reported with the ICU memory tool. Among 657 patients who were randomized (median [interquartile range] age, 62 [51-70] years; 126 women [37.2%]), 339 (51.6%) completed the trial. At 3 months, significant PTSD symptoms were reported by 49 of 164 patients (29.9%) in the intervention group vs 60 of 175 (34.3%) in the control group (risk difference, -4% [95% CI, -15% to 6%]; P = .39). The median (interquartile range) IES-R score was 12 (5-25) in the intervention group vs 13 (6-27) in the control group (difference, -1.47 [95% CI, -1.93 to 4.87]; P = .38). There were no significant differences in any of the 6 prespecified comparative secondary outcomes. Among patients who received mechanical ventilation in the ICU, the use of an ICU diary filled in by clinicians and family members did not significantly reduce the number of patients who reported significant PTSD symptoms at 3 months. These findings do not support the use of ICU diaries for preventing PTSD symptoms. ClinicalTrials.gov Identifier: NCT02519725.

Identifiants

pubmed: 31310299
pii: 2738291
doi: 10.1001/jama.2019.9058
pmc: PMC6635906
doi:

Banques de données

ClinicalTrials.gov
['NCT02519725']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Pagination

229-239

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Crit Care Med. 2000 Aug;28(8):3044-9
pubmed: 10966293
Crit Care Med. 2001 Mar;29(3):573-80
pubmed: 11373423
Crit Care Med. 2001 Jul;29(7):1370-9
pubmed: 11445689
Crit Care Med. 2003 Oct;31(10):2456-61
pubmed: 14530751
Intensive Care Med. 2004 Mar;30(3):456-60
pubmed: 14767589
Nurs Crit Care. 2005 Jan-Feb;10(1):31-4
pubmed: 15739637
Addict Behav. 2008 Aug;33(8):1039-47
pubmed: 18501524
Crit Care Med. 2009 Jan;37(1):184-91
pubmed: 19050634
Nurs Crit Care. 2009 Mar-Apr;14(2):61-7
pubmed: 19243522
Chest. 2009 Mar;135(3):678-687
pubmed: 19265087
JAMA. 2009 Mar 25;301(12):1231-41
pubmed: 19318651
Intensive Crit Care Nurs. 2010 Oct;26(5):278-87
pubmed: 20692158
Crit Care. 2010;14(5):R168
pubmed: 20843344
Crit Care Med. 2011 Jan;39(1):112-8
pubmed: 21037472
Crit Care. 2011;15(1):R41
pubmed: 21272307
Crit Care Med. 2012 Feb;40(2):502-9
pubmed: 21946660
Crit Care Med. 2012 Apr;40(4):1088-97
pubmed: 22080631
Crit Care Med. 2012 Jul;40(7):2033-40
pubmed: 22584757
Am J Crit Care. 2012 Nov;21(6):386-93; quiz 394
pubmed: 23117902
Aust Crit Care. 2014 Feb;27(1):28-35
pubmed: 23938098
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
Crit Care. 2013 Dec 18;17(6):253
pubmed: 24351578
PLoS One. 2014 Oct 16;9(10):e110146
pubmed: 25329581
Eur Respir J. 2015 May;45(5):1341-52
pubmed: 25614168
Crit Care Med. 2015 May;43(5):1121-9
pubmed: 25654178
Am J Respir Crit Care Med. 2016 Jan 15;193(2):154-62
pubmed: 26378963
Gen Hosp Psychiatry. 2016 Sep-Oct;42:32-5
pubmed: 27638969
Intensive Care Med. 2017 Apr;43(4):473-484
pubmed: 28197680
Am J Respir Crit Care Med. 2018 Jan 1;197(1):66-78
pubmed: 28872898
Trials. 2017 Nov 15;18(1):542
pubmed: 29141694
N Engl J Med. 2018 Jun 21;378(25):2365-2375
pubmed: 29791247
Crit Care Med. 2018 Aug;46(8):1328-1333
pubmed: 29794546
Med Klin Intensivmed Notfmed. 2019 Feb;114(1):68-76
pubmed: 29995235
Crit Care Med. 2018 Dec;46(12):1914-1922
pubmed: 30119073
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820

Auteurs

Maité Garrouste-Orgeas (M)

Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM, Paris Diderot University, Department of Biostatistics - HUPNVS. - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.
Department of Biostatistics, Outcomerea, Paris, France.
Medical unit, French British Hospital, Levallois-Perret, France.

Cécile Flahault (C)

LPPS-EA4057, Laboratory of Psychopathology and Health Process, Paris Descartes University, Paris, France.

Isabelle Vinatier (I)

Medical ICU, Les Oudaries Hospital, La Roche-sur-Yon, Vendée, France.

Jean-Philippe Rigaud (JP)

Department of Intensive Care, Dieppe General Hospital, Dieppe, France.

Nathalie Thieulot-Rolin (N)

Medical-Surgical ICU, General Hospital, Melun, France.

Emmanuelle Mercier (E)

CRICS-TRIGGERSEP group, Medical-Surgical ICU, Tours University Hospital, Tours, France.

Antoine Rouget (A)

Medical-Surgical ICU, Rangueil University Hospital, Toulouse, France.

Hubert Grand (H)

Medical-Surgical ICU, Hospital Robert Boulin, Libourne, France.

Olivier Lesieur (O)

Medical-Surgical ICU, General Hospital, La Rochelle, France.

Fabienne Tamion (F)

Medical ICU, University Medical Center, Rouen, France.
INSERM U-1096, University of Rouen, Rouen, France.

Rebecca Hamidfar (R)

Medical ICU, Albert Michallon University Hospital, Grenoble, France.

Anne Renault (A)

Medical ICU, La Cavale Blanche University Hospital, Brest, France.

Erika Parmentier-Decrucq (E)

Group of medical ICUs, Lille University Hospital, Lille, France.

Yannick Monseau (Y)

Medical-Surgical ICU, General Hospital, Périgueux, France.

Laurent Argaud (L)

Medical ICU, Edouard Herriot University Hospital, Lyon, France.

Cédric Bretonnière (C)

Medical ICU, Nantes University Hospital, Nantes, France.
EA3826, Laboratory of Clinical and Experimental Therapeutics of Infections, University of Nantes, Nantes, France.

Alexandre Lautrette (A)

Medical ICU, Gabriel-Montpied University Hospital, Clermont Ferrand, France.
LMGE UMR CNRS 6023, University of Clermont-Ferrand, Clermont Ferrand, France.

Julio Badié (J)

Medical-Surgical ICU, General Hospital Belfort-Montbéliard, Belfort, France.

Eric Boulet (E)

Medical ICU, Beaumont General Hospital, Beaumont, France.

Bernard Floccard (B)

Medical ICU, Hospices Civils de Lyon, Edouard Herriot University Hospital, Lyon, France.

Xavier Forceville (X)

Medical-Surgical ICU, Great Hospital of East Francilien, Meaux, France.

Eric Kipnis (E)

Surgical ICU, Lille University Hospital, Lille, France.

Lilia Soufir (L)

Medical-Surgical ICU, Saint Joseph Hospital Network, Paris, France.

Sandrine Valade (S)

Medical ICU, Saint Louis University Hospital, Paris, France.

Naike Bige (N)

Medical ICU, Saint Antoine University Hospital, Paris, France.

Alain Gaffinel (A)

Medical-Surgical ICU, Gustave Roussy Cancer Campus, Villejuif, France.

Olfa Hamzaoui (O)

Medical Surgical ICU, University Hospital Paris -Sud, Beclère University Hospital, Clamart, France.

Georges Simon (G)

Medical-Surgical ICU, General Hospital, Troyes, France.

Marina Thirion (M)

Medical-Surgical ICU, General Hospital Victor Dupouy, Argenteuil, France.

Lila Bouadma (L)

Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM, Paris Diderot University, Department of Biostatistics - HUPNVS. - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.
Medical ICU, Bichat University Hospital, Paris, France.

Audrey Large (A)

Medical ICU, François Mitterrand University Hospital, Dijon, France.

Jean-Paul Mira (JP)

Medical ICU, Cochin University Hospital, Paris Centre Hospital Group, AP-HP, Paris, France.

Nora Amdjar-Badidi (N)

Medical-Surgical ICU, General Hospital René Dubos, Pontoise, France.

Mercé Jourdain (M)

Group of medical ICUs, Lille University Hospital, Lille, France.
Lille University, Inserm U1190, Lille, France.

Paul-Henri Jost (PH)

Surgical ICU, Henri Mondor University Hospital, Créteil, France.

Virginie Maxime (V)

Medical ICU, Raymond Poincaré University Hospital, Garches, France.

François Santoli (F)

Medical ICU, General Hospital Robert Ballanger, Aulnay-Sous-Bois, France.

Stéphane Ruckly (S)

Department of Biostatistics, Outcomerea, Paris, France.

Christel Vioulac (C)

LPPS-EA4057, Laboratory of Psychopathology and Health Process, Paris Descartes University, Paris, France.

Marie Annick Leborgne (MA)

LPPS-EA4057, Laboratory of Psychopathology and Health Process, Paris Descartes University, Paris, France.

Lucie Bellalou (L)

LPPS-EA4057, Laboratory of Psychopathology and Health Process, Paris Descartes University, Paris, France.

Léonor Fasse (L)

LPPS-EA4057, Laboratory of Psychopathology and Health Process, Paris Descartes University, Paris, France.

Benoit Misset (B)

Medical ICU, University Medical Center, Rouen, France.

Sébastien Bailly (S)

Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM, Paris Diderot University, Department of Biostatistics - HUPNVS. - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.
Grenoble Alpes University, INSERM, University hospital Grenoble Alpes, HP2, Grenoble, France.

Jean-François Timsit (JF)

Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM, Paris Diderot University, Department of Biostatistics - HUPNVS. - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.
Department of Biostatistics, Outcomerea, Paris, France.
Medical ICU, Bichat University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH